Skip to main content
main-content

Zeitschrift

Nuclear Medicine and Molecular Imaging

Nuclear Medicine and Molecular Imaging OnlineFirst articles

21.11.2017 | Original Article

Evaluating the Predictive Ability of Initial Staging F-18 FDG PET/CT for the Prognosis of Non-Hodgkin Malignant Lymphoma Patients Who Underwent Stem Cell Transplantation

Since the establishment of combined rituximab chemotherapy complex, the survival rate and prognosis of malignant non-Hodgkin lymphoma (NHL) patients improved [ 1 , 2 ]. However, some patients show poor treatment response or recurrence after the …

20.11.2017 | Review

Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors

Peptide receptor radionuclide therapy (PRRT) is a systemic cytotoxic radiation therapy using a compound of β-emitting radionuclide chelated to a peptide for the treatment of tumor with overexpressed specific cell receptor such as somatostatin …

16.11.2017 | Review

Deep Learning in Nuclear Medicine and Molecular Imaging: Current Perspectives and Future Directions

Recent advances in deep learning have impacted various scientific and industrial fields. Due to the rapid application of deep learning in biomedical data, molecular imaging has also started to adopt this technique. In this regard, it is expected …

13.11.2017 | Editorial

Message from the President-Elect of the World Federation of Nuclear Medicine and Biology

07.11.2017 | Original Article

The Predictive Values of Lesion Size, F-18 FDG Avidity and I-131 Avidity for the Clinical Outcome of I-131 Treatment in Patients with Metastatic Differentiated Thyroid Carcinoma Only in the Lung

Papillary and follicular carcinomas of the thyroid gland, often referred together as differentiated thyroid carcinoma (DTC), are one of the most curable cancers and are associated with a favorable prognosis. However, 4–23% of patients with DTC …

Aktuelle Ausgaben

Über diese Zeitschrift

Nuclear Medicine and Molecular Imaging (Nucl Med Mol Imaging) publishes papers on nuclear medicine and a wide range of related sciences including radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. The journal also presents original works relating to molecular imaging research, such as the development of molecular imaging probes, reporter imaging assays, imaging cell trafficking, imaging endo(exo)genous gene expression, and imaging signal transduction. Content includes original articles, reviews, case reports, editorials, interesting images, and letters to the editor. Nucl Med Mol Imaging is an official journal of the Korean Society of Nuclear Medicine. KSNM members read this journal plus the official journals of the EANM and the Japanese Nuclear Medicine Society online for free.

Ethical Standards


Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirementsAll contributions should also follow the good publication practice guidelines for medical journals, which were established by Korean Association of Medical Journal Editors (http://www.kamje.or.kr).

Conflict of Interest


When an author or the institution of the author has a relationship, financial or otherwise, with individuals or organizations that could influence the author’s work inappropriately, a conflict of interest may exist. Examples of potential conflicts of interest may include but are not limited to academic, personal, or political relationships; employment; consultancies or honoraria; and finical connections such as stock ownership and funding. Although an author may not feel that there are conflicts, disclosure of relationships and interests that could be viewed by others as conflicts of interest affords a more transparent and prudent process. All authors must disclose any actual or potential conflict of interest. The Journal may publish such disclosures if judged to be important to readers.

Weitere Informationen